Speaker illustration

Doctor Kerstin Piayda

Justus-Liebig University of Giessen, Giessen (Germany)

Member of:

European Society of Cardiology

Kerstin Piayda is a cardiology resident and research associate at the CVC Frankfurt, Germany. Her main research interests revolve around clinical studies in interventional cardiology with focus on structural heart disease (TAVI, LAAO) and endovascular acute stroke treatment. She holds a medical degree from the Goethe-University Frankfurt and is currently engaged in the two year Executive Master of Science in Health Economics, Outcomes and Management in Cardiovascular Sciences program offered by the London School of Economics and Political Sciences. She received an ESC scholarship to participate in this program. Kerstin has undergone experimental basic research training with focus on cellular changes in aortic valve stenosis at the Cardiovascular Research Laboratory Düsseldorf and also participates in numerous world-wide, multi center clinical trials such as GALILEO, ENVISAGE TAVI, ENTRUST HF, ASAP-TOO, FORWARD, AMULET IDE.

Embolization of percutaneous left atrial appendage closure devices: timing, management and associated clinical outcomes

Event: ESC Congress 2023

Topic: Left Atrial Appendage (LAA) Closure

Session: Left atrial appendage occlusion: where are we now and where are we going?

Thumbnail

The learning curve for interventional cardiologists performing acute stroke interventions

Event: ESC Congress 2021 - The Digital Experience

Topic: Acute Intervention

Session: Stroke ePosters

Thumbnail

Regular hours vs. on-call endovascular interventions for acute stroke treatment: initial single-center experience by interventional cardiologists

Event: ESC Congress 2021 - The Digital Experience

Topic: Acute Intervention

Session: Stroke ePosters

Thumbnail

Performance of the Corevalve Evolut R and PRO in severely calcified anatomies: a propensity-score matched analysis

Event: ESC Congress 2020

Topic: Intervention

Session: Valvular Heart Disease ePosters

Thumbnail

Use and success evaluation of percutaneous aortic balloon valvuloplasty in different hemodynamic entities of severe aortic stenosis in the TAVR era

Event: ESC Congress 2020

Topic: Intervention

Session: Valvular Heart Disease ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb